Showing 1,301 - 1,320 results of 60,794 for search '(( 5 ((we decrease) OR (nn decrease)) ) OR ( 50 ((ns decrease) OR (a decrease)) ))', query time: 1.11s Refine Results
  1. 1301
  2. 1302
  3. 1303
  4. 1304
  5. 1305

    Decreased Platelet Count in Patients Receiving Continuous Veno-Venous Hemofiltration: A Single-Center Retrospective Study by Buyun Wu (563610)

    Published 2014
    “…<div><p>Background</p><p>A decreased platelet count may occur and portend a worse outcome in patients receiving continuous renal replacement therapy (CRRT). …”
  6. 1306
  7. 1307

    Paxilline and NS11021 sensitive mitoBK channels give rise to a 190 pS conductance, which is absent in BK-negative mitoplasts. by Ewa Soltysinska (605651)

    Published 2014
    “…(<b>B</b>) Four different conductances were observed in mitoplasts from cardiomyocytes in a voltage step protocol with 2 seconds at +80 mV followed by 3 seconds at holding potential (−50 mV). …”
  8. 1308

    Compound CID 9998128 Is a Potential Multitarget Drug for Alzheimer’s Disease by Nguyen Quoc Thai (5348798)

    Published 2018
    “…Moreover, the compound dose-dependently decreases β-site amyloid precursor protein cleaving enzyme (BACE-1) activity with EC<sub>50</sub> value in micromolar range. …”
  9. 1309

    Compound CID 9998128 Is a Potential Multitarget Drug for Alzheimer’s Disease by Nguyen Quoc Thai (5348798)

    Published 2018
    “…Moreover, the compound dose-dependently decreases β-site amyloid precursor protein cleaving enzyme (BACE-1) activity with EC<sub>50</sub> value in micromolar range. …”
  10. 1310
  11. 1311

    Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

    Published 2013
    “…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC<sub>50</sub> concentration of fenretinide during different time points (24–48–72 hours). …”
  12. 1312
  13. 1313

    Pre-treatment with CDDO-Me decreases IR-induced DNA damage in a variety of non-cancerous cells. by Mariam El-Ashmawy (678638)

    Published 2014
    “…(A) HBEC 3KT, (B) HME1, and (C) PBMCs were treated with CDDO-Me 18 hours prior to IR, then mounted on slides 30 min post-IR. …”
  14. 1314
  15. 1315

    Table_1_What have we learned from a case of convalescent plasma treatment in a two-time kidney transplant recipient COVID-19 patient? A case report from the perspective of viral lo... by Fabian Aldunate (3935021)

    Published 2023
    “…In addition, we found evidence of an increase in antibody titers after transfusion, accompanied by a decrease in the levels of several cytokines responsible for cytokine storm.…”
  16. 1316

    Image_1_What have we learned from a case of convalescent plasma treatment in a two-time kidney transplant recipient COVID-19 patient? A case report from the perspective of viral lo... by Fabian Aldunate (3935021)

    Published 2023
    “…In addition, we found evidence of an increase in antibody titers after transfusion, accompanied by a decrease in the levels of several cytokines responsible for cytokine storm.…”
  17. 1317
  18. 1318

    Replication of challenge viruses in mice immunized with the VN1203ΔNS1 virus. by Julia Romanova (225341)

    Published 2009
    “…a<p>Mice with lung virus load <1.5 log<sub>10</sub> TCID<sub>50</sub>/ml were classified as being protected.…”
  19. 1319
  20. 1320

    Structure–Activity Studies of 1<i>H</i>‑Imidazo[4,5‑<i>c</i>]quinolin-4-amine Derivatives as A<sub>3</sub> Adenosine Receptor Positive Allosteric Modulators by Lucas B. Fallot (14106171)

    Published 2022
    “…We previously reported 1<i>H</i>-imidazo[4,5-<i>c</i>]quinolin-4-amines as A<sub>3</sub> adenosine receptor (A<sub>3</sub>AR) positive allosteric modulators (PAMs). …”